Joanna Poutou

476 total citations
17 papers, 231 citations indexed

About

Joanna Poutou is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Joanna Poutou has authored 17 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in Joanna Poutou's work include Virus-based gene therapy research (9 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and CAR-T cell therapy research (5 papers). Joanna Poutou is often cited by papers focused on Virus-based gene therapy research (9 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and CAR-T cell therapy research (5 papers). Joanna Poutou collaborates with scholars based in Spain, Canada and Iran. Joanna Poutou's co-authors include Rubén Hernández-Alcoceba, María Buñuales, José I. Quetglas, Manuela González-Aparicio, Cristian Smerdou, Pilar Alzuguren, Carlos Bravo‐Pérez, Raquel Bartolomé-Casado, Carolina S. Ilkow and Jesús Prìeto and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Cellular and Molecular Life Sciences.

In The Last Decade

Joanna Poutou

17 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Poutou Spain 10 115 111 95 53 50 17 231
Qibin Liao China 10 99 0.9× 56 0.5× 94 1.0× 41 0.8× 69 1.4× 14 244
Anitha Rao United States 6 444 3.9× 247 2.2× 96 1.0× 65 1.2× 67 1.3× 13 570
Jim Ackland United States 6 80 0.7× 64 0.6× 37 0.4× 67 1.3× 93 1.9× 10 259
Shinwa Shibata Japan 11 203 1.8× 101 0.9× 50 0.5× 51 1.0× 167 3.3× 19 420
Urszula Eksmond United Kingdom 12 163 1.4× 49 0.4× 74 0.8× 41 0.8× 285 5.7× 15 457
Adina Pelusio South Korea 5 88 0.8× 232 2.1× 233 2.5× 37 0.7× 102 2.0× 6 331
Nicolas Laroudie France 4 197 1.7× 179 1.6× 66 0.7× 67 1.3× 21 0.4× 6 258
Amy Denton United Kingdom 2 164 1.4× 164 1.5× 115 1.2× 35 0.7× 46 0.9× 6 262
Radwa Ewaisha United States 7 224 1.9× 73 0.7× 52 0.5× 16 0.3× 20 0.4× 13 305
Klaus Kuehlcke Germany 9 212 1.8× 190 1.7× 128 1.3× 32 0.6× 95 1.9× 17 320

Countries citing papers authored by Joanna Poutou

Since Specialization
Citations

This map shows the geographic impact of Joanna Poutou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Poutou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Poutou more than expected).

Fields of papers citing papers by Joanna Poutou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Poutou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Poutou. The network helps show where Joanna Poutou may publish in the future.

Co-authorship network of co-authors of Joanna Poutou

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Poutou. A scholar is included among the top collaborators of Joanna Poutou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Poutou. Joanna Poutou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Martin, Nikolas T., Mathieu J. F. Crupi, Zaid Taha, et al.. (2023). Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals. 16(5). 709–709. 4 indexed citations
2.
Rezaei, Reza, et al.. (2021). Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter. Journal of Visualized Experiments. 2 indexed citations
3.
Azad, Taha, Reza Rezaei, Ragunath Singaravelu, et al.. (2021). A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion. Nanomaterials. 11(3). 807–807. 7 indexed citations
4.
Poutou, Joanna, et al.. (2020). Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment. Cytokine & Growth Factor Reviews. 56. 102–114. 8 indexed citations
5.
Azad, Taha, Ragunath Singaravelu, Mathieu J. F. Crupi, et al.. (2020). Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization. Membranes. 10(9). 215–215. 15 indexed citations
6.
Serna‐Gallego, Ana, María Buñuales, Joanna Poutou, et al.. (2018). Inhibition of adenovirus infection by mifepristone. Antiviral Research. 159. 77–83. 20 indexed citations
7.
Poutou, Joanna, et al.. (2017). Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment. Journal of Controlled Release. 268. 247–258. 9 indexed citations
8.
Hernández-Alcoceba, Rubén, et al.. (2016). Gene Therapy Approaches Against Cancer Using in Vivo and ex Vivo Gene Transfer of Interleukin-12. Immunotherapy. 8(2). 179–198. 30 indexed citations
9.
Quetglas, José I., Erkuden Casales, Joanna Poutou, et al.. (2016). Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane. Cellular and Molecular Life Sciences. 73(20). 3897–3916. 16 indexed citations
10.
Nistal‐Villán, Estanislao, Joanna Poutou, María Buñuales, et al.. (2016). A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling. PLoS ONE. 11(3). e0152031–e0152031. 6 indexed citations
11.
Nistal‐Villán, Estanislao, María Buñuales, Joanna Poutou, et al.. (2015). Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model. Molecular Cancer. 14(1). 210–210. 15 indexed citations
12.
Poutou, Joanna, María Buñuales, Manuela González-Aparicio, et al.. (2015). Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model. Gene Therapy. 22(9). 696–706. 36 indexed citations
13.
Poutou, Joanna, María Buñuales, José I. Quetglas, et al.. (2015). 110. Safety and Antitumor Effect of Oncolytic and Helper-Dependent Adenoviruses Expressing Interleukin-12 Variants in a Hamster Pancreatic Cancer Model. Molecular Therapy. 23. S46–S46. 28 indexed citations
14.
Alzuguren, Pilar, Sandra Hervás‐Stubbs, Gloria González‐Aseguinolaza, et al.. (2014). Transient depletion of specific immune cell populations to improve adenovirus‐mediated transgene expression in the liver. Liver International. 35(4). 1274–1289. 13 indexed citations
15.
Acosta‐Rivero, Nelson, Joanna Poutou, Alexis Musacchio, et al.. (2009). Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant. Biological Research. 42(1). 41–56. 13 indexed citations
16.
Pérez, Ángel, Nelson Acosta‐Rivero, Viviana Falcón, et al.. (2006). Ultrastructural and Immunological Characterization of Hepatitis C Core Protein-DNA Plasmid Complexes. 2(3). 71–76. 5 indexed citations
17.
Acosta‐Rivero, Nelson, Joanna Poutou, Viviana Falcón, et al.. (2005). Interaction of a C-terminal Truncated Hepatitis C Virus Core Protein with Plasmid DNA Vaccine Leads toin vitro Assembly of Heterogeneous Virus-like Particles. American Journal of Infectious Diseases. 1(1). 66–72. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026